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Summary
Cellular senescence is accompanied by a senescence-associated
secretory phenotype (SASP). We show here that primary human
senescent CD8+ T cells also display a SASP comprising chemoki-
nes, cytokines and extracellular matrix remodelling proteases
that are unique to this subset and contribute to age-associated
inflammation. We found the CD8+ CD45RA+CD27 EMRA subset
to be the most heterogeneous, with a population aligning with
the na€ıve T cells and another with a closer association to the
effector memory subset. However, despite the differing pro-
cesses that give rise to these senescent CD8+ T cells once
generated, they both adopt a unique secretory profile with no
commonality to any other subset, aligning more closely with
senescence than quiescence. Furthermore, we also show that the
SASP observed in senescent CD8+ T cells is governed by p38
MAPK signalling.
Key words: aging; cytokine; inflammation; microarray; SASP;
T cell.
Introduction
Immune senescence results from defects in T-cell immunity and is also
characterized by a low-grade chronic inflammatory state (Macaulay
et al., 2013). Little is known about the source of the inflammation that
fuels most age-related diseases; however, it may derive from an age-
related decline in homoeostatic immune function, resistance to endoge-
nous microbes or senescent cells (Tchkonia et al., 2013). The senescent
phenotype is not just proliferative arrest; rather, it is a widespread
change in protein expression and secretion, including pro-inflammatory
cytokines, chemokines, growth factors and proteases, termed the
senescence-associated secretory phenotype or SASP (Coppe et al.,
2008). Consequently, senescent cells can alter the tissue microenviron-
ment and affect neighbouring cells through paracrine signalling. The
SASP is highly conserved between species (Coppe et al., 2010) and
occurs in a variety of cells types (Erusalimsky & Kurz, 2005; Salminen
et al., 2011) that may be specifically adapted to control different
biological processes (Akbar et al., 2016).
The SASP was originally thought to result from persistent activation of
the DNA damage response (Rodier et al., 2009); however, it is now
known to be regulated by p38 MAPK, which was shown to be both
necessary and sufficient for its development in fibroblasts (Freund et al.,
2011). The chronic and sustained activation of p38 MAPK differs
substantially from the response to acute stress and was found to follow
the kinetics of SASP development. Furthermore, siRNA interference of
p38 MAPK was shown to significantly reduce the secreted levels of most
SASP factors (Freund et al., 2011). To date, the SASP has predominantly
been characterized in fibroblast cell culture models or aged mice (Coppe
et al., 2008, 2010; Aoshiba et al., 2013), with very few reports of a
SASP being found in the human immune system with either age or
differentiation (Frasca et al., 2017).
Senescent CD8+ T cells are found within the CD27CD28 popula-
tion (Weng et al., 2009; Parish et al., 2010), and these highly differen-
tiated T cells can be further divided using CD45RA. T cells that re-express
CD45RA within this subset have multiple characteristics of senescence,
including a low proliferative activity, high levels of DNA damage and the
loss of telomerase activity (Henson et al., 2014, 2015). We have also
shown that p38 MAPK signalling, which is increased in highly differen-
tiated CD8+ T cells (Henson et al., 2014), is involved in the loss of
telomerase activity and proliferative capacity and that blockade of p38
MAPK activity with a specific small-molecule inhibitor can restore both
proliferation and telomerase activity (Lanna et al., 2013; Henson et al.,
2014, 2015) in these cells. However, surprisingly the CD45RA-re-
expressing senescent T cells do not have critically short telomeres (Di
Mitri et al., 2011; Riddell et al., 2014), suggesting that senescence in
these cells may be induced by other mechanisms including DNA damage
by increased ROS production (Henson et al., 2014). Indeed, we show
here that the CD45RA+CD27 T cells are the most heterogeneous CD8+
T-cell subset that pertain from either the na€ıve or effector memory CD8+
T cells, and carry with them hallmarks of each of these subsets.
In this study, we demonstrate that irrespective of the derivation of
CD8+ CD45RA+CD27 T cells, these primed cells exhibit a unique highly
inflammatory secretory profile characteristic of the SASP, and we also
provide evidence that ADAM28 can be used as a functional marker of
senescence in CD8+ T cells. Furthermore, we show that the secretory
phenotype in CD8+ CD45RA+CD27 T cells is controlled through p38
MAPK signalling, which contributes to age-associated inflammation.
Results
CD8+ T cells display a senescence-associated secretory
phenotype
To determine whether senescent CD8+ T cells exhibit a secretory
phenotype similar to that seen in senescent fibroblasts (Rodier et al.,
2009), we compared the gene expression profiles of CD45RA/CD27-
definedCD8+ T-cell subsets using Affymetrix U133 plus 2 arrays. The gene
expression patterns of sorted central memory (CM; CD45RA-CD27+),
effector memory (EM; CD45RACD27) and effector memory T cells that
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re-express CD45RA (EMRA; CD45RA+CD27) CD8+ T cells were com-
pared to the na€ıve (N; CD45RA+CD27+) CD8+ subset so that direct
comparisons between all three groups could bemade. Six individuals were
chosen for their even distribution of CD8+ T cells between the four
CD45RA/CD27-defined subsets: averageN, 38%;CM,21%;EM,7%;and
EMRA, 25%.We found that 1472geneswere differentially expressed only
in the senescent EMRA population when compare to the N subset (FDR-
corrected P-value higher than or equal to 0.01). The number of unique
genes fell to 519 when the EMRA population was compared to the EM
cells, indicating that EMRA CD8+ T cells reflect a unique state of gene
expression.Whenanalysed for genes relating to soluble factors secretedby
the senescent EMRA CD8+ T cells, we found 53 genes to be significantly
upregulated (Fig. 1A). The SASP components in CD8+ EMRA T cells are
comprised mainly of proteases, chemokines and interleukins as well as
other inflammatory, growth and insoluble factors such as extracellular
matrix components (Fig. 1B). Of the inflammatory and immune-mod-
ulatory cytokines and chemokines, TNF-a, IL-18, IL-29, CCL5, CCL16 and
CCL23 were all found to be significantly upregulated in the EMRA subset.
We and others have previously published that EMRA T cells secrete high
levels of TNF-a (Hamann et al., 1997; Henson et al., 2015). However, we
validatehere the relative increase ingeneexpressionof IL-18 andCCL16by
flow cytometry, showing them both to be significantly increased in the
CD8+ EMRA subset (Fig. 1C). Of note, the cytokines IL-1b and IL-6, shown
to be highly secreted by senescent fibroblasts (Coppe et al., 2008), are
expressed by the EMRA subset, but the EM cells produce the highest
amounts of these cytokines and are not a SASP-defining feature in CD8+ T
cells. However, EMRA cells do produce more IL-6 and IL-1b than the N or
CM subsets (Fig. S1A).
The unique secretory nature of CD8+ EMRA T cells also included
increased secretion of proteases, 23 of the 53 significantly upregulated
secreted factors are proteases (Fig. 1A,B), including cathepsins and
serine proteases but also the ADAM family of disintegrin and metallo-
proteases. In particular, ADAM28, which was found to be one of the
most upregulated genes in the EMRA subset, was found to be secreted
at significantly higher levels by ELISA in the EMRA subset when
compared to the other T-cell subsets (Fig. 1D). ADAMs are regulatory
proteins that pose both proteolytic activity and the ability to modulate
intercellular adhesion. Indeed, as well as ADAM28’s involvement in
membrane-bound TNF-a cleavage (Jowett et al., 2012), the disintegrin
domain of ADAM28 also serves as a ligand for the integrin a4b1 (Bridges
et al., 2002). Therefore, the upregulation of proteases may also indicate
changes to the migratory potential of the EMRA subset. Further evidence
for the altered migratory nature of the EMRA CD8+ T cells can be found
from the unique chemokine receptor profile expressed by these cells
(Fig. 1E). With the expression of CX3CR1 directly ex vivo on the EMRA
subset being >90% by flow cytometry (Fig. 1F), potentially mediating
their adhesion to the endothelium in the absence of stimulation. This
finding therefore suggests that CD8+ EMRA T cells contribute to local
inflammation and the amplification of the inflammatory response owing
to their adhesion to the endothelium and the recruitment of other
inflammatory mediators.
Regulation of the secretory phenotype seen in CD8+
CD45RA+CD27 T cells
It has recently been shown that dysfunctional mitochondria can promote
a distinct secretory phenotype in human cells and mice termed
mitochondrial dysfunction-associated senescence (MiDAS) (Wiley
Christopher et al., 2016). The authors showed that the MiDAS resulted
from an NADH-AMPK-p53-dependent pathway that elicited a SASP but
lacked IL-1-dependent factors. We have previously shown CD8+ EMRA T
cells to display mitochondrial dysfunction (Henson et al., 2014). There-
fore, we investigated whether the CD8+ EMRA SASP was also governed
by a p53-AMPK-dependent pathway. However, while we found the
EMRAs to express the highest level of p-p53 (Fig. 2A), they, unlike their
CD4+ senescent counterparts (Lanna et al., 2014), did not display any
AMPK phosphorylation, either directly ex vivo (Fig. S1B) or following
stimulation (Fig. 2B). Why this should be the case is unclear, but it may be
due to the differing roles of CD4+ and CD8+ T cells; furthermore, CD4+ T
cells have been shown to have a higher mitochondrial mass than CD8+ T
cells (Cao et al., 2014) regulated by AMPK (Jornayvaz & Shulman, 2010).
We found that the CD45RA+CD27 EMRA subset was the most
heterogeneous of the four subsets, shown here by PCA (Fig. 2C), with a
population aligning with the na€ıve subset and a population with a closer
association with the effector memory subset. Furthermore, unsupervised
clustering revealed the EMRA populations to align with the EM and N
populations (data not shown). We then split the EMRA subset into two
groups depending on whether they aligned to the na€ıve subset, na€ıve-like
EMRAs, effectors or effector-like EMRAs and analysed themicroarray data
for genes relating to senescence and the SASP (Fig. 2Dand E, respectively).
Indeed, when comparing the gene expression profiles of the na€ıve and
na€ıve-like EMRAs and EM and EM-like EMRAs for genes associated with
senescence,we found thena€ıve subsets to be closely aligned, as are the EM
subsets (Fig. 2D). Each EMRA subset expressed cell cycle inhibitors more
closely allied to its cognate counterpart; na€ıve and na€ıve-like EMRAs
displayed higher expression levels of cyclin D (ccnd1), pRB and erk
(map2k6),while the EMand EM-like EMRAs showed increased amounts of
Chk1 (chek1) and TP53I3. These cell cycle regulators and kinases can
switch on senescence or quiescence phenotypes; however, genes
controlling telomerase activity such as TERT and the shelterin complex
are repressed inboth EMRApopulations, suggesting that both these EMRA
phenotypes are senescent rather than quiescent (Fig. S1C). In addition,
when assessing genes associated with the SASP (Fig. 2E), we found no
alignment of the two EMRA populations with either the na€ıve or the EM
subsets, indicating that despite the differing processes that give rise to
these senescent CD8+ T cells once generated, they both adopt a unique
secretory profile with no commonality to any other subset, aligning more
closely with senescence than quiescence.
Analysis of the microarray data revealed that a key difference between
the two EMRA populations was the expression of CD28, with N-like
EMRAs showing high expression levels of this molecule (Fig. S1D).
Therefore, to formally investigate the heterogeneity of the EMRA subset,
we used CCR7, CD45RA, CD28 and CD27 to define senescence. When
Fig. 1 CD8+ EMRA T cells display a unique secretory phenotype. (A) Shown are the secreted factors which were significantly increased (P < 0.05) in the CD8+ EMRA T-cell
subset. For each protein, the relative gene expression is displayed as the average value of six donors. Signals above baseline are yellow; signals below baseline are blue. The
heat map key shows log-fold changes from baseline. (B) Pie chart showing the relative percentage of secreted factors split into key functions. (C) Representative flow
cytometry plots and cumulative data of IL-18 and CCL16 on CD8+ CD45RA/CD27-defined T-cell subsets following an 18-hour stimulation with 0.5 lg mL1 anti-CD3.
Graphs show the mean  SEM for four donors. (D) Graph showing the production of ADAM28 by the four CD8+ T-cell subsets following an 18-hour stimulation with
0.5 lg mL1 anti-CD3 and 5 ng mL1 IL-2. Graph shows the mean  SEM for three donors. (E) Heat map showing the relative gene expression of chemokine receptors that
were significantly upregulated (P < 0.05) by the CD8+ EMRA T-cell subset. (F) Flow cytometry plot and graph showing the expression of CX3CR1 on the four CD45RA/CD27-
defined CD8+ T-cell subsets. Graph shows the mean  SEM for four donors. P-values were calculated using a repeated-measures ANOVA with the Tukey correction used for
post hoc testing.
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Fig. 2 Regulation of the secretory phenotype seen in CD8+ EMRA T cells. (A) Representative flow cytometry plots of phosphorylated p53. Graph depicts the expression of
p-p53 in CD8+ CD45RA/CD27-defined T-cell subsets. Graph shows the mean  SEM for nine donors. (B) Flow cytometry plots and graph showing the expression of
phosphorylated AMPK in CD8+ T-cell subsets following an 18-hour stimulation with 0.5 lg mL1 anti-CD3. Graph shows the mean  SEM for 10 donors. P-values were
calculated using a repeated-measures ANOVA with the Tukey correction used for post hoc testing. (C) PCA of CD8+ CD45RA/CD27-defined T-cell subsets. (D) Heat map
showing the relative gene expression of senescence genes for the N and EM CD45RA/CD27-defined subsets (six donors) compared to the na€ıve-like and EM-like EMRA
subsets (three donors each). (E) Relative gene expression changes for genes controlling the secreted SASP factors in N and EM CD45RA/CD27-defined subsets compared to
the na€ıve-like and EM-like EMRA subsets. The heat map keys show log-fold changes from baseline.
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CD8+ T cells are gated on CD45RA+CCR7 cells, this highly differentiated
population is found to be highly heterogeneous. This population was
composed of a na€ıve-like population expressing bothCD27 andCD28 and
more differentiated population that have lost both these markers
(Fig. 3A). The CD28+CD27+ and CD28CD27 population were found
to differentially express p-p53; however, both populations expressed
higher levels of p-p53 thanall otherCD8+T-cell subsets (Fig. 3B).Whenwe
assessed the expression of p-AMPK in the CD28+CD27+ and
CD28CD27 senescent populations, we found the CD28+CD27+ pop-
ulation to express high levels of p-AMPK, akin to the expression levels
observed in less differentiated CD45RA/CD27 T-cell subsets (Fig. 3C),
indicating that there is a na€ıve-like population of senescent CD8+ T cells
displaying a unique senescent phenotype expressing p53 and AMPK and
an EM-like population expressing p53 only.
MAPK activity is necessary to induce a SASP in senescent
CD8+ T cells
We then went on to investigate whether the SASP observed by the
na€ıve- or EM-like EMRA subset was regulated in a p38 MAPK-dependent
manner, like that observed in fibroblasts (Freund et al., 2011). Likewise,
we show here that the CD8+ EMRA T-cell SASP is also controlled by p38
MAPK, for blocking the p38 MAPK pathway with the small-molecule
inhibitor BIRB 796 resulting in the downregulation of 34 of the 53
secreted factors (Fig. 4A). We found the relative gene expression profiles
of all the cytokines and chemokines to be reduced regardless of EMRA
subset, with the responses of IL-18 and CCL16 in the four CD27/
CD45RA-defined subsets being validated by flow cytometry (Fig. 4B). In
addition, the expression of over half the secreted proteases was also
reduced, shown here by the decline in ADAM28 production measured
by ELISA (Fig. 4D). Finally, while the production of IL-1b and IL-6 was not
highly expressed in the CD8+ EMRA subset, their production was
controlled by p38 MAPK (Fig. S1E). In summary, we show here that the
senescent CD8+ EMRA population has a unique secretory phenotype
governed by p38 MAPK.
Discussion
Senescence was initially described as an irreversible cell cycle arrest;
however, it has now been shown to be more than a process of reduced
proliferative capacity but rather an active process regulating cellular
homoeostasis in response to numerous stresses, such as DNA damage or
a reduction in growth factors (Campisi, 2005; Akbar & Henson, 2011).
The ability of senescent cells to modulate their growth-promoting
pathways marks them as different from quiescent cells which are held in
a nonproliferating state. The hyperfunctional nature of senescent cells is
A)
C)B)
Fig. 3 Characterization of the senescent profile of CD8+ CD45RA+CCR7 CD28/CD27 T cells. (A) Representative flow cytometry plots showing phenotypic staining using
CD45RA/CCR7 and the different CD28/CD27 staining pattern observed in CD45RA/CCR7-defined EMRA cells from two donors. (B) Flow cytometry plots and graphs
depicting p-p53 expression in ex vivo CD8+ CD45RA/CD27-defined (left axis) and CD45RA+CCR7 CD28/CD27-defined subsets (right axis). (C) Plots and graph showing the
expression of phosphorylated AMPK in CD8+ T-cell subsets following an 18-h stimulation with 0.5 lg mL1 anti-CD3 in the above subsets. Graphs show the mean  SEM
for nine donors. P-values were calculated using a paired t-test or a repeated-measures ANOVA with the Tukey correction used for post hoc testing.
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characterized by the secretion of growth factors, inflammatory media-
tors, proteases, extracellular matrix components termed the senescence-
associated secretory phenotype (SASP). These secreted factors accumu-
lated in tissues and altered the structure and cellular microenvironment
(Campisi et al., 2011). We show here that senescent CD8+ CD45RA/
CD27-defined EMRA T cells display a unique secretory profile charac-
teristic of the SASP.
The components of the SASP have been shown to vary depending on
the cell type, with differing levels of cytokines and other inflammatory
mediators being found in epithelial cells and mesenchymal cells (Xu
et al., 2015). Indeed, we show here that senescent CD8+ T cells
exhibited a SASP which differs to that reported for fibroblasts and B and
NK cells, in that it is not defined by the expression of IL-1b and IL-6. This
may relate to our finding that EMRA T cells are unable to phosphorylate
mTOR (Henson et al., 2014), a key molecule in the stabilization and
translation of inflammatory cytokine mRNAs (Kafasla et al., 2014).
However, senescent CD8+ T cells do secrete high levels of IL-18, a pro-
inflammatory cytokine in the IL-1 family that induces IFN-c production.
Nevertheless, CD8+ EMRA T cells do produce more inflammatory
cytokines than EM T cells, potentially reinforcing both the senescent
and inflammatory phenotype of these cells.
We also demonstrate the CD8+ T-cell SASP to predominantly
comprise proteases, which have the potential to alter tissue structure
and organization through the cleavage of membrane-bound receptors,
signalling ligands, extracellular matrix proteins or other components in
the tissue microenvironment (van Deursen, 2014). One protease in
particular, ADAM28, was found to be highly upregulated in senescent
CD8+ T cells and offers a novel functional biomarker of T-cell
senescence. ADAMs (a disintegrin and metalloprotease) are a family of
transmembrane proteins which control interactions with the extracellular
matrix through proteolytic modification of cell surface proteins, as well
as acting as adhesion molecules (Seals & Courtneidge, 2003). ADAM28
has been shown to be involved in membrane-bound TNF-a cleavage
(Jowett et al., 2012), as well as serving as a ligand for the integrin a4b1,
where it is thought to target the active protease to substrates at the site
of cell–cell contact (Bridges et al., 2002). Additionally, ADAM28 has also
been shown to bind P-selectin glycoprotein ligand-1 (PSGL-1) enhancing
cell adhesion to endothelial cells and subsequent migration into tissues
(Shimoda et al., 2007). Therefore, the enhanced expression of ADAM28
in senescent CD8+ T cells together with high expression levels of
CX3CR1 directly ex vivo has the potential to alter the migration of these
cells. The increased inflammatory nature of senescent CD8+ T cells is
associated with acute renal rejection and vascular injury (Dedeoglu et al.,
2016); furthermore, the adhesion and migration of T cells in inflamed
vessels have also been linked to endothelial barrier dysfunction (Yang
et al., 2009). Therefore, it will be instructive to assess the damage
senescent T cell cause by their extravasation.
The CD8+ CD45RA/CD27-defined EMRA subset was also found to be
highly heterogenic, displaying characteristics of either na€ıve or effector
memory cells. Heterogeneity within memory T cells has been documented to
occurduringaging (Hensonet al., 2015;Pulkoet al., 2016).Ahumanmemory
population with a na€ıve-like phenotype (CCR7+CD45RA+CD28intCD95lo) was
foundtoincreaseduringagingandexhibitedatranscriptomedistinctfromother
T-cell subsets (Pulkoet al., 2016). The authors found this subset to have long
telomeres and respond to persistent viral infections. We show here the
diverse nature of a more differentiated subset of memory cells and
postulate that unlike the na€ıve memory cells, these EMRA cells are an
antigen-experienced functionally senescent population with characteris-
tics of na€ıve or effector cells generated via different mechanisms.
Senescence can be triggered via many routes, and as such, the SASP
components also vary; for example, primary lung fibroblasts generated via
proteasome inhibition showed a unique combination of SASP constituents
compared to the induction of senescence through replication or oxidative
stress (Maciel-Baron et al., 2016). Ongoing work suggests that the
senescent phenotype of our EMRA subset is generated by replicative
senescence and homoeostatic mechanisms, but the resulting SASP, while
not identical, represents a unique phenotype that is distinct from the other
T-cell subsets.
We also demonstrated that the senescent CD8+ EMRA T-cell SASP is
predominantly but not totally governed by p38 MAPK signalling, akin to
that demonstrated for fibroblasts (Freund et al., 2011) and B cells (Frasca
et al., 2017). In these fibroblast and B-cell models, p38 MAPK activated
a SASP downstream of AMPK, and we show here that in the na€ıve-like
EMRA subset, this may also be the case; however, the EM-like EMRAs
were found to be governed independently of AMPK. The existence of
AMPK-independent mechanisms has been demonstrated; for example,
the induction of senescence by genotoxic stress gives rise to a secretory
phenotype regulated by NF- jB and not AMPK (Wiley Christopher et al.,
2016). We show here a population of na€ıve-like senescent cells that
produced a secretome potentially via AMPK and an EM-like population
that lack AMPK activity; therefore, a fuller analysis of the controlling
factors in the EMRA subsets is warranted.
In summary, despite the plasticity of the CD8+ EMRA T-cell subset, the
resulting cells are functionally senescent, as demonstrated by both
proliferative arrest and the increased production and secretion of
inflammatory mediators characteristic of a SASP. The components of this
secretory phenotype appear to be tailored to the unique migratory
behaviour of the EMRA T cell with the potential to enhance their
pathogenicity.
Experimental procedures
Blood sample collection and isolation
Heparinized peripheral blood samples were taken from healthy volun-
teers (age range: 32–55 n = 6). Further, donors were recruited to
validate observations arising from microarray analysis (age range: 24–
45). Healthy volunteers were individuals who had not had an infection or
immunization within the last month, no known immunodeficiency or
any history of chemotherapy or radiotherapy, and were not receiving
systemic steroids within the last month or any other immunosuppressive
medications within the last 6 months. PBMC were isolated using Ficoll-
Paque (Amersham Biosciences, Little Chalfont, Buckinghamshire, UK).
All samples were obtained in accordance with the ethical committee of
Fig. 4 The secretory phenotype of CD8+ EMRA T cells is regulated in a p38 MAPK-dependent manner. (A) Heat map showing the changes in the secreted factors produced
by CD8+ EMRA T cells following inhibition of the p38 MAPK pathway using BIRB796. For each protein, the relative gene expression is displayed as the average value of six
donors. Signals above baseline are yellow; signals below baseline are blue. The heat map key shows log-fold changes from baseline. (B) Flow cytometry plots and cumulative
data of IL-18 and CCL16 in CD8+ EMRA T-cell subset following an 18-hour stimulation with or with our BIRB796. Graphs show the mean  SEM for four donors. (C) Graph
showing the production of ADAM28 from stimulated CD8+ EMRAs following blockade of the p38 MAPK pathway using BIRB796. Graph shows the mean  SEM for three
donors. P-values were calculated a repeated-measures ANOVA with the Tukey correction used for post hoc testing.
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Royal Free and University College Medical School and the North East-
York Research Ethics Committee 16/NE/0073.
Flow cytometric analysis and cell sorting
Flow cytometric analysis was performed using the following antibodies:
CD8 PerCP (SK1), CD45RA BV605 (HI100), CD27 BV421 (O323), CD28
BV785 (CD28.2), CCR7 PE-Cy7 (G0343H7), KLRG1 PE (2f1/KLRG1) and
CX3CR1 (K0I24E1), from BioLegend. For intracellular staining, the follow-
ing antibodies were used: IL-18/IL-1F4 propeptide PE (74801) and CCL16/
HCC-4 FITC (70218) (both from R&D Systems); Ki67 PE (Ki67), p53 Alexa
Fluor 647 (1C12), p-p53 (Ser15, 16G8) Alexa Fluor 647 and p-AMPK
(Thr172, 40H9) (all from Cell Signaling Technology); and goat anti-rabbit
IgGH&LAlexa Fluor 488 (Abcam,Milton, Cambridge, UK). Detection of IL-
18, CCL16 and p53was carried out following an 18-hour stimulationwith
plate-coated anti-CD3 (OKT3), and p-AMPK was detected after a 2-hour
starvationperiod in PBS followedby a 1-hour stimulationwith plate-bound
anti-CD3 (OKT3). Following surface staining, PBMCswere fixed in solution
A (ThermoFisher, Paisley, Renfrewshire, UK) for 15 min at room temper-
ature followed by permeabilization with solution B (ThermoFisher, Paisley,
Renfrewshire) plus antibody for 20 min at room temperature. All samples
were run using an LSR II (BD Biosciences, Winnersh, Woking, UK) and
analysed using FlowJo software (Treestar).
CD8+ T cells were purified by positive selection (Miltenyi Biotec, Bisley,
Woking, UK) according to the manufacturer’s instructions. Positively
selectedCD8+ T cells were labelledwithCD27 FITC (M-T271) andCD45RA
APC (HI100) (both from BD Biosciences) and sorted using a FACSAria (BD
Biosciences). The purity of CD8 T-cell subsets was assessed by flow
cytometry.
Measurement of ADAM28
CD45RA/CD27-defined CD8+ T-cell subsets were sorted, and 2 9 105
cells were cultured with 0.5 lg mL1 plate-coated anti-CD3 (OKT3) and
5 ng mL1 rhIL-2. Cell lysates were collected at 48 h for the measure-
ment of ADAM28 using the human ADAM28 ELISA kit (LSBio) according
to the protocol provided by the manufacturer.
Cytometric array cytokine profiling
IL-1b concentration in culture supernatants was measured using the
Cytometric Bead Array (BD Biosciences), according to the manufacturer’s
protocol. The lower limit of detection for each analyte was 1.5 pg mL1.
p38 MAPK inhibition
Signalling through p38 MAPK on either PBMCs or CD27/CD45RA-
defined CD8+ subsets was blocked by adding the small-molecule
inhibitor BIRB796 (Selleck) at a final concentration of 500 nM for the
indicated time periods.
Microarray data acquisition
Cells purified by FACS sorting were stimulated for 2 h with 0.5 lg mL1
plate-coated anti-CD3 (OKT3) and 5 ng mL1 rhIL-2 before RNA isolation
using the ARCTURUS PicoPure Isolation Kit (ThermoFisher). The concen-
tration of small quantities of RNA was determined using the Nanodrop.
Linear amplification of 10 ng of total RNA was performed using the
Ovation Biotin RNA amplification and labelling system (NuGEN). Frag-
mented, labelled cDNA was hybridized to Affymetrix U133 plus 2 arrays.
Microarray analysis
Raw microarray intensity data were normalized by robust multi-array
average (RMA) (Irizarry et al., 2003). RMA data sets each were then
filtered to exclude microRNA, open reading frame, nonprotein coding,
pseudogene, antisense, small nucleolar RNA and uncharacterized RNA.
Final analysis thus was performed on data sets that contained log-
transformed signal intensities for 18 646 known genes that have a well-
annotated official gene symbol. The analysis of variance (ANOVA) and
multitest correction for P-values were used to identify differentially
expressed genes. Lists of genes with significant variation of the
expression levels (P < 0.01) were generated using a 0.02 FDR criterion
as a significant cut-off. Gene Cluster 3.0 software was used to centre
the genes and cluster them using Kendall’s tau coefficient. Heat maps
of the clustered data were created using Java TreeView software (de
Hoon et al., 2004). Principal component analysis was generated using
the Partek software package. The data discussed in this publication
have been deposited in NCBI’s Gene Expression Omnibus (Edgar et al.,
2002) and are accessible through GEO Series accession number
GSE98640 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE98640).
Statistical analysis
GraphPad Prism was used to perform statistical analysis. Statistical
significance was evaluated using the paired Student t-test or a
repeated-measures ANOVA with the Tukey correction used for post
hoc testing. Differences were considered significant when P was
<0.05.
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